Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome
- PMID: 27468812
- PMCID: PMC9150202
- DOI: 10.1017/S0950268816001436
Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome
Abstract
Shiga toxin-producing Escherichia coli (STEC) is an important cause of gastroenteritis (GE) and haemolytic uraemic syndrome (HUS). Incidence of STEC illness is largely underestimated in notification data, particularly of serogroups other than O157 ('non-O157'). Using HUS national notification data (2008-2012, excluding 2011), we modelled true annual incidence of STEC illness in Germany separately for O157 and non-O157 STEC, taking into account the groups' different probabilities of causing bloody diarrhoea and HUS, and the resulting difference in their under-ascertainment. Uncertainty of input parameters was evaluated by stochastic Monte Carlo simulations. Median annual incidence (per 100 000 population) of STEC-associated HUS and STEC-GE was estimated at 0·11 [95% credible interval (CrI) 0·08-0·20], and 35 (95% CrI 12-145), respectively. German notification data underestimated STEC-associated HUS and STEC-GE incidences by factors of 1·8 and 32·3, respectively. Non-O157 STEC accounted for 81% of all STEC-GE, 51% of all bloody STEC-GE and 32% of all STEC-associated HUS cases. Non-O157 serogroups dominate incidence of STEC-GE and contribute significantly to STEC-associated HUS in Germany. This might apply to many other countries considering European surveillance data on HUS. Non-O157 STEC should be considered in parallel with STEC O157 when searching aetiology in patients with GE or HUS, and accounted for in modern surveillance systems.
Keywords: Escherichia coli O157; Burden of illness; Monte Carlo method; enterohaemorrhagic Escherichia coli; incidence.
Figures



Similar articles
-
Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):726-30. doi: 10.1007/s10096-003-1025-0. Epub 2003 Nov 12. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14614596
-
Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016.Euro Surveill. 2019 Feb;24(8):1800068. doi: 10.2807/1560-7917.ES.2019.24.8.1800068. Euro Surveill. 2019. PMID: 30808442 Free PMC article.
-
The epidemiology of haemolytic uraemic syndrome in England, 2009-2023: An analysis of national surveillance data.J Infect. 2025 Aug;91(2):106551. doi: 10.1016/j.jinf.2025.106551. Epub 2025 Jul 14. J Infect. 2025. PMID: 40669773
-
Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.J Infect. 2019 Aug;79(2):75-94. doi: 10.1016/j.jinf.2019.05.018. Epub 2019 May 28. J Infect. 2019. PMID: 31150744 Review.
-
Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.Med Mal Infect. 2018 May;48(3):167-174. doi: 10.1016/j.medmal.2017.09.012. Epub 2017 Oct 18. Med Mal Infect. 2018. PMID: 29054297 Review.
Cited by
-
Virulence gene profiles and phylogeny of Shiga toxin-positive Escherichia coli strains isolated from FDA regulated foods during 2010-2017.PLoS One. 2019 Apr 1;14(4):e0214620. doi: 10.1371/journal.pone.0214620. eCollection 2019. PLoS One. 2019. PMID: 30934002 Free PMC article.
-
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.Toxins (Basel). 2021 Apr 26;13(5):306. doi: 10.3390/toxins13050306. Toxins (Basel). 2021. PMID: 33925836 Free PMC article. Review.
-
Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.Microbiol Spectr. 2022 Aug 31;10(4):e0066022. doi: 10.1128/spectrum.00660-22. Epub 2022 Jun 22. Microbiol Spectr. 2022. PMID: 35730965 Free PMC article.
-
Development and Validation of Shiga Toxin-Producing Escherichia coli Immunodiagnostic Assay.Microorganisms. 2019 Aug 21;7(9):276. doi: 10.3390/microorganisms7090276. Microorganisms. 2019. PMID: 31438570 Free PMC article.
-
Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.BMC Microbiol. 2017 Nov 9;17(1):215. doi: 10.1186/s12866-017-1123-2. BMC Microbiol. 2017. PMID: 29121863 Free PMC article.
References
-
- Hadler JL, et al. Ten-year trends and risk factors for non-o157 shiga toxin-producing Escherichia coli found through shiga toxin testing, Connecticut, 2000–2009. Journal of Clinical Infectious Diseases 2011; 53: 269–276. - PubMed
-
- Hedican EB, et al. Characteristics of O157 versus non-O157 shiga toxin-producing Escherichia coli infections in Minnesota, 2000–2006. Journal of Clinical Infectious Diseases 2009; 49: 358–364. - PubMed
-
- Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073–1086. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical